Lauren Frymus Email

Project Manager . Tangen Biosciences

Current Roles

Employees:
12
Revenue:
$1.9M
About
Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut. The company developed the TangenDxâ„¢ platform for fast and accurate detection of targeted DNAs and RNAs directly from specimens by using rotary rapid isothermal nucleic acid detection. The Tangen system consists of the TangenDxâ„¢ disc and the GeneSparkâ„¢ instrument, an automated amplification device. The TangenDxâ„¢ platform, which does not require laboratory facilities, is expected to deliver faster, simpler, more sensitive detection at a lower cost than other commercial technologies. Current tests in development include COVID-19, Candida auris, sepsis causing bacterial panel, antibiotic resistance genes, and a fungal blood panel. The system can process samples from whole blood, sputum, skin swabs, nasopharyngeal swabs, etc. The TangenDx FluA/B, RSV, and SARS-CoV-2 Panel assay planned to be released by the upcoming fall season.
Tangen Biosciences Address
20 Commercial Street Branford, Connecticut
Branford, CT
United States
Tangen Biosciences Email

Past Companies

Tangen Biosciences, Inc.Project Manager
Tangen Biosciences, Inc.Scientist
Southern Connecticut State UniversityGraduate Research Fellow

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.